Recro Pharma (REPH) Reports Q2 Loss of $0.83/Share

August 11, 2016 7:15 AM EDT
Get Alerts REPH Hot Sheet
Price: $7.13 -2.73%

Today's EPS Names:
PG, CFG, GE, More
Trade REPH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Recro Pharma (NASDAQ: REPH) reported Q2 EPS of ($0.83), versus ($0.17) reported last year. Revenue for the quarter came in at $17.3 million, versus $18.7 million reported last year.

For earnings history and earnings-related data on Recro Pharma (REPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment